The most dangerous competitor facing Indian pharma today is not a Chinese API manufacturer. It is a 27-year-old ML engineer in Bengaluru who just chose Anthropic over a biotech offer. He will spend the next decade helping build the systems that make the generics model obsolete.
New episode. 20 minutes. For CXOs and investors who want the uncomfortable version of this conversation. Listen in.
